Guerbet’s Post

Webinar alert ‼️ Join me on July 11th at 4PM CET for an exciting webinar on the use of polynucleotides in treating facial erythema.   Polynucleotide injections have been widely used in Asian countries, primarily South Korea, for the treatment of facial erythema.   What you will learn: - An overview of the available clinical data - Insights from data collected in countries where Pluryal PN products have been used for treating facial erythema, particularly rosacea. - The protocols used for these treatments. - The results and patient feedback. Secure your spot here as places are limited: https://bit.ly/4cetxPB #pluryal

Exciting News from Points Location Intelligence and DOCERE  We are proud to introduce WeSee, our innovative Location Intelligence (LI) platform designed for the Healthcare, Medical, and Bio Pharmaceutical sectors.  WeSee stands out by harnessing location data to provide in-depth insights into Israel's healthcare landscape, including detailed mappings of community physicians and health services. It also offers crucial external demographic data to enhance strategic planning and resource allocation. Moreover, WeSee seamlessly integrates your organization’s internal geographic data with external data, creating a dynamic, interactive map that aids informed decision-making.  Discover how WeSee can revolutionize your data analytics in healthcare. For more information, contact us at office@docere.co.il or Points_LI@points.co.il The Solution crafted by human smarts (Dudi Elias, Yafit Ben Haim, Yigal Aviv), but the videos, sounds, and tunes? Totally GEN AI-made! 😉 #WeSee #HealthcareInnovation #GIS #LocationIntelligence #DataDrivenDecisions

Watch to learn more about metatarsus adductus and the UNFO brace for treatment in this video interview with Izak Daizade, MD of UNFO Med Ltd. WATCH: https://lnkd.in/epSvmgPW

Watch to learn more about metatarsus adductus and the UNFO brace for treatment in this video interview with Izak Daizade, MD of UNFO Med Ltd. WATCH: https://lnkd.in/epSvmgPW

World Antimicrobial Awareness Week (#WAAW) serves as a reminder that AMR is a pressing public health challenges of our time. The theme for World AMR Awareness Week (WAAW) 2024 is “Educate. Advocate. Act now.” This year’s theme aims to encourage the global community to educate stakeholders about AMR, push for bold commitments, and implement tangible measures to combat it. The DRAIGON initiative is expected to boost the fight against #AMR. It aims to create an in vitro diagnostic device driven by AI and genome sequencing. This tool will be designed to predict antimicrobial resistance in real-time, enabling healthcare providers to select the most effective treatments for patients infected with resistant pathogens. The project is part of a global European Vaccine Initiative (EVI)-led consortium: UMCG research, CAMTECH, Orthopädisches Spital Speising, Health-Ecore, Isala (ziekenhuis), The Johns Hopkins University, Sandoz, Spitali Universitar Shefqet Ndroqi; , with a collective mission to raise awareness and advocate for urgent actions to tackle AMR. Read more ➡ https://lnkd.in/d3Z5aCWM  --- #DRAIGONEU #DRAIGONAMR #antimicrobialresistance #artificialintelligence #EUFunded

Interesting in supporting one of Video Journal of Oncology (VJOncology)'s inaugural post-ASCO highlights webinars? 📥 If you'd like to find out more, drop me a message and let's have a chat. ☕ Even better, if you're attending #ASCO24 and you'd like to find out more - let's grab a coffee to discuss. #ASCO24 #VJOncology #educationalwebinar #supportingHCPeducation #oncologyeducation

Lack of rapid diagnostic tools for pathogen identification and AMR detection is a key fundamental issue for addressing the inexorable spread of #AMR. Recognising the efforts of #DRAIGONEU in pursuing this key piece of the puzzle.

A quick reminder about ISPOR Europe 2024!! Medalis Ltd will be presenting a poster at ISPOR Europe 2024 on November 19th, 2024 in Barcelona! Our poster, titled: “Evaluating the Economic Impact of Real-World Costs in nAMD Treatment Using Neutral Theory: A UK Perspective,” dives deep into the economic costs nAMD clinics face. Our findings revealed the importance of non-drug costs and clinic strain impacts which are often overlooked in traditional cost-effectiveness assessments. If you're interested in real-world evidence and health economics, and how these are shaping the treatment landscape for nAMD, we ask you to join us and explore our findings firsthand! To book a meeting with us please scan the QR code below and select a slot on the 19th of November. Looking forward to insightful discussions and sharing our research with the wider ISPOR community. See you there! #ISPOREurope2024 #nAMD #HealthEconomics #MedalisLtd #CostEffectiveness #ResearchInnovation

💡 Want to learn more about AMR? Check out RaDAR's new animated series🎬 It explains the #AMR challenge and how #innovation through #PPI is key to tackling it. 🌍

Check this out! The RaDAR PPI just launched the first episode on how this #procurement of #innovation is aiming to tackle the #AMR challenge!